PRRT2 and neoplasm: It inhibits the development of tumor cells by inhibiting the pathways like PI3K/AKT, RAS/MAPK, and PLCy/PKC by using the receptors: V.E.G.F.R., F.G.F.R., and P.D.G.F.R.